Similarly, persistent presentation of gp100 melanoma peptide in incomplete Freund’s adjuvant, which protects the antigen from degradation, led to sequestration of antigen-specific CD8+ T cells at the vaccine site (26). This evidence concerns the gene CD8A and melanoma.